{"transactions":[{"id":900298,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":1000000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":900297,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":600000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":900296,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T16:45:18.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":0.4,"value":400000.0,"ownership":{"direct":true},"balance_after":1050000,"source":{"system":"sec-edgar","filing":"0000914190-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419026000025/form4.xml","form_type":"4"}},{"id":978646,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T17:40:13.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"derivative":{"exercise_price":0.813,"exercise_date":"2026-05-01","expiration_date":"2035-12-03","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000914190-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000091419025000048/form4.xml","form_type":"4"}},{"id":1132891,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-27","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":1.6478,"value":57673.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6345 to $1.65 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1132890,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-23","kind":"purchase","planned":false,"acquired":true,"shares":13000,"price":1.6433,"value":21362.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6333 to $1.6497 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1132889,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-27T18:34:31.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.6834,"value":3366.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6875 to $1.6794 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001062993-25-010396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299325010396/form4.xml","form_type":"4"}},{"id":1758764,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T16:13:35.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":62500,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001062993-23-019448","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712459/000106299323019448/form4.xml","form_type":"4"}},{"id":379029,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:02:12.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1002,"price":120.61,"value":120851.22,"ownership":{"direct":true},"balance_after":43550,"source":{"system":"sec-edgar","filing":"0001415889-21-001198","document":"form4-03022021_040353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001198/form4-03022021_040353.xml","form_type":"4"}},{"id":379028,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:02:12.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":7060,"price":121.58,"value":858354.8,"ownership":{"direct":true},"balance_after":44552,"source":{"system":"sec-edgar","filing":"0001415889-21-001198","document":"form4-03022021_040353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001198/form4-03022021_040353.xml","form_type":"4"}},{"id":379678,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-23T23:29:08.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":39994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,331 on February 19, 2022, 13,331 on February 19, 2023, and 13,332 on February 19, 2024."}],"balance_after":39994,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":39994},"source":{"system":"sec-edgar","filing":"0001415889-21-000886","document":"form4-02232021_030225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000886/form4-02232021_030225.xml","form_type":"4"}},{"id":379677,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:29:08.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":7802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":51612,"source":{"system":"sec-edgar","filing":"0001415889-21-000886","document":"form4-02232021_030225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000886/form4-02232021_030225.xml","form_type":"4"}},{"id":387915,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-07-28T21:16:26.000Z","date":"2020-07-24","kind":"tax_withholding","acquired":false,"shares":1650,"price":100.82,"value":166353.0,"ownership":{"direct":true},"balance_after":43810,"source":{"system":"sec-edgar","filing":"0001179110-20-008528","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020008528/edgar.xml","form_type":"4"}},{"id":393963,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:13:10.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":1781,"price":77.89,"value":138722.09,"ownership":{"direct":true},"balance_after":45460,"source":{"system":"sec-edgar","filing":"0001179110-20-002893","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002893/edgar.xml","form_type":"4"}},{"id":393962,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:13:10.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":4720,"price":79.19,"value":373776.8,"ownership":{"direct":true},"balance_after":47241,"source":{"system":"sec-edgar","filing":"0001179110-20-002893","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002893/edgar.xml","form_type":"4"}},{"id":394473,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2020-02-25T22:35:48.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":76198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,399 on February 21, 2021, 25,399 on February 21, 2022, and 25,400 on February 21, 2023."}],"balance_after":76198,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":76198},"source":{"system":"sec-edgar","filing":"0001179110-20-002290","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002290/edgar.xml","form_type":"4"}},{"id":394472,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:35:48.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":51961,"source":{"system":"sec-edgar","filing":"0001179110-20-002290","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002290/edgar.xml","form_type":"4"}},{"id":401301,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2019-07-25T22:48:36.000Z","date":"2019-07-24","kind":"tax_withholding","acquired":false,"shares":1650,"price":88.74,"value":146421.0,"ownership":{"direct":true},"balance_after":39461,"source":{"system":"sec-edgar","filing":"0001179110-19-008828","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008828/edgar.xml","form_type":"4"}},{"id":406322,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:21:05.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":1002,"price":78,"value":78156.0,"ownership":{"direct":true},"balance_after":41111,"source":{"system":"sec-edgar","filing":"0001179110-19-003111","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003111/edgar.xml","form_type":"4"}},{"id":406321,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:21:05.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":2309,"price":77.23,"value":178324.07,"ownership":{"direct":true},"balance_after":42113,"source":{"system":"sec-edgar","filing":"0001179110-19-003111","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003111/edgar.xml","form_type":"4"}},{"id":406876,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2019-02-26T22:05:44.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":81578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,192 on February 22, 2020, 27,193 on February 22, 2021, and 27,193 on February 22, 2022."}],"balance_after":81578,"derivative":{"exercise_price":75.9,"exercise_date":"2020-02-22","expiration_date":"2029-02-21","underlying":"Common shares","underlying_shares":81578},"source":{"system":"sec-edgar","filing":"0001179110-19-002637","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002637/edgar.xml","form_type":"4"}},{"id":406875,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2019-02-26T22:05:44.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":15563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":44422,"source":{"system":"sec-edgar","filing":"0001179110-19-002637","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002637/edgar.xml","form_type":"4"}},{"id":413261,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2018-07-26T21:08:40.000Z","date":"2018-07-24","kind":"tax_withholding","acquired":false,"shares":1151,"price":63.2,"value":72743.2,"ownership":{"direct":true},"balance_after":28859,"source":{"system":"sec-edgar","filing":"0001179110-18-009934","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018009934/edgar.xml","form_type":"4"}},{"id":418541,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2018-02-21T23:32:58.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":110146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 36,716 on 02/16/2019, 36,715 on 02/16/2020, and 36,715 on 02/16/2021."}],"balance_after":110146,"derivative":{"exercise_price":59.94,"exercise_date":"2019-02-16","expiration_date":"2028-02-15","underlying":"Common shares","underlying_shares":110146},"source":{"system":"sec-edgar","filing":"0001179110-18-002531","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002531/edgar.xml","form_type":"4"}},{"id":418540,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2018-02-21T23:32:58.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":20030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":30010,"source":{"system":"sec-edgar","filing":"0001179110-18-002531","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002531/edgar.xml","form_type":"4"}},{"id":424557,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2017-07-26T21:08:14.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":69024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,008 on 07/24/2018, 23,008 on 07/24/2019, and 23,008 on 07/24/2020."}],"balance_after":69024,"derivative":{"exercise_price":50.74,"exercise_date":"2018-07-24","expiration_date":"2027-07-23","underlying":"Common shares","underlying_shares":69024},"source":{"system":"sec-edgar","filing":"0001179110-17-010711","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010711/edgar.xml","form_type":"4"}},{"id":424556,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15691,"kind":"person","name":"BRYNELSEN CHARLES","position":1,"cik":"0001712459","reported_name":"BRYNELSEN CHARLES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2017-07-26T21:08:14.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":9980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":9980,"source":{"system":"sec-edgar","filing":"0001179110-17-010711","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010711/edgar.xml","form_type":"4"}}]}